These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 21237278)
1. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China. Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278 [TBL] [Abstract][Full Text] [Related]
2. Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses. Jia L; Wang Z; Yu Y Chin Med J (Engl); 2003 Jun; 116(6):941-3. PubMed ID: 12877812 [TBL] [Abstract][Full Text] [Related]
3. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers. Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Yu Y Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891 [TBL] [Abstract][Full Text] [Related]
5. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Beasley DW; Li L; Suderman MT; Guirakhoo F; Trent DW; Monath TP; Shope RE; Barrett AD Vaccine; 2004 Sep; 22(27-28):3722-6. PubMed ID: 15315852 [TBL] [Abstract][Full Text] [Related]
6. [Progress in the research of phenotype and genotype of Japanese encephalitis virus in China]. Chen N; Yu YX Bing Du Xue Bao; 2013 Jun; 29(4):457-64. PubMed ID: 23895014 [TBL] [Abstract][Full Text] [Related]
7. Partial cross-protection between Japanese encephalitis virus genotype I and III in mice. Wei J; Wang X; Zhang J; Guo S; Pang L; Shi K; Liu K; Shao D; Qiu Y; Liu L; Widén F; Li B; Ma Z PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007601. PubMed ID: 31374086 [TBL] [Abstract][Full Text] [Related]
8. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus. Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722 [TBL] [Abstract][Full Text] [Related]
9. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China. Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360 [TBL] [Abstract][Full Text] [Related]
10. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice. Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus. Li Y; Xu M; Chen L; Zhu J; Ye J; Liu X; Sun Y; Chen H; Cao S Vaccine; 2009 Oct; 27(43):6004-10. PubMed ID: 19665607 [TBL] [Abstract][Full Text] [Related]
12. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893 [TBL] [Abstract][Full Text] [Related]
13. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China. Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783 [TBL] [Abstract][Full Text] [Related]
14. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies. Ferguson M; Johnes S; Li L; Heath A; Barrett A Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945 [TBL] [Abstract][Full Text] [Related]
15. Immune response in mice infected with the attenuated Japanese encephalitis vaccine strain SA14-14-2. Lee T; Komiya T; Watanabe K; Aizawa C; Hashimoto H Acta Virol; 1995 Jun; 39(3):161-4. PubMed ID: 8578998 [TBL] [Abstract][Full Text] [Related]
16. [Molecular characteristics of the genome of G I of Japanese encephalitis virus isolated from the specimen collected from viral encephalitis case for the first time]. Li J; Fu SH; Wang LH; Gao XY; Wang HY; Ye XF; Zhao SY; Liu CT; Zhu WY; Wang L; Liang GD Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):84-6. PubMed ID: 23002539 [TBL] [Abstract][Full Text] [Related]
17. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study. Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496 [TBL] [Abstract][Full Text] [Related]
18. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine. Appaiahgari MB; Vrati S Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774 [TBL] [Abstract][Full Text] [Related]
19. Characterization of immune responses induced by inactivated, live attenuated and DNA vaccines against Japanese encephalitis virus in mice. Li J; Chen H; Wu N; Fan D; Liang G; Gao N; An J Vaccine; 2013 Aug; 31(38):4136-42. PubMed ID: 23845821 [TBL] [Abstract][Full Text] [Related]
20. Complete protection for mice conferred by a DNA vaccine based on the Japanese encephalitis virus P3 strain used to prepare the inactivated vaccine in China. Zheng X; Yu X; Wang Y; Turtle L; Cui M; Wang R; Yin C Virol J; 2020 Aug; 17(1):126. PubMed ID: 32831096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]